SCHEMBL845064

SCHEMBL845064

COC(=O)N1c2ccccc2C[C@H]1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3Cc4ccccc4N3C(=O)OC)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPC1 O15118 1/20 0.45
PABPC1 P11940 1/20 0.44
EP300 Q09472 1/20 0.44
CREBBP Q92793 1/20 0.44
LMNA P02545 2/20 0.43
KCNH2 Q12809 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272510 0.87 MAPK1 (0.39) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL13272433 0.86 MAPK1 (0.38) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL845258 0.81 MAPK1 (0.60) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL845364 0.78 LMNA (0.52) NPC1LMNA
SCHEMBL845003 0.77 F2 (0.58) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL845030 0.77 ALDH1A1 (0.49) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL844884 0.75 HTT (0.48) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL10299164 0.75 NPC1 (0.76) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL10281278 0.75 NPC1 (0.76) MAPK1ALDH1A1HTTCYP2C9CYP2C19
SCHEMBL845227 0.75 NPC1 (0.76) MAPK1ALDH1A1HTTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed